BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31107612)

  • 1. Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments.
    Fiore M; Di Franco S; Alfieri A; Passavanti MB; Pace MC; Kelly ME; Damiani G; Leone S
    Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):683-692. PubMed ID: 31107612
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing frequency of gram-positive cocci and gram-negative multidrug-resistant bacteria in spontaneous bacterial peritonitis.
    Alexopoulou A; Papadopoulos N; Eliopoulos DG; Alexaki A; Tsiriga A; Toutouza M; Pectasides D
    Liver Int; 2013 Aug; 33(7):975-81. PubMed ID: 23522099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis.
    Fiore M; Gentile I; Maraolo AE; Leone S; Simeon V; Chiodini P; Pace MC; Gustot T; Taccone FS
    Eur J Gastroenterol Hepatol; 2018 Mar; 30(3):329-336. PubMed ID: 29303883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features, microbial spectrum, and antibiotic susceptibility patterns of spontaneous bacterial peritonitis in cirrhotic patients.
    Zhang X; Li XX; Song JW; Zhang XC; Zhen C; Bi JF; Lu FY; Chen SM; Dan Huo D; Zhao P; Zhang DW; Tu B; Bao CM; Wang FS; Huang L
    Dig Liver Dis; 2023 Nov; 55(11):1554-1561. PubMed ID: 37778896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
    Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
    World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
    ELshamy RM; Oda MS; Saeed MA; Ramadan RA
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):655-663. PubMed ID: 35352700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
    Friedrich K; Nüssle S; Rehlen T; Stremmel W; Mischnik A; Eisenbach C
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1191-5. PubMed ID: 26676553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMPACT OF MICROBIOLOGICAL CHANGES ON SPONTANEOUS BACTERIAL PERITONITIS IN THREE DIFFERENT PERIODS OVER 17 YEARS.
    Almeida PRL; Leão GS; Gonçalves CDG; Picon RV; Tovo CV
    Arq Gastroenterol; 2018; 55(1):23-27. PubMed ID: 29561972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A contemporary situation in the antimicrobial treatment of the secondary peritonitis].
    Vyhnánek F; Vranková J
    Rozhl Chir; 2005 Sep; 84(9):466-71. PubMed ID: 16250620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
    Voulgaris GL; Voulgari ML; Falagas ME
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
    de Mattos AA; Costabeber AM; Lionço LC; Tovo CV
    World J Gastroenterol; 2014 Oct; 20(39):14079-86. PubMed ID: 25339797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms.
    Sharma R; Park TE; Moy S
    Clin Ther; 2016 Mar; 38(3):431-44. PubMed ID: 26948862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the profiles of causative agents and antibiotic resistance rate for spontaneous bacterial peritonitis: an analysis of cultured microorganisms in recent 12 years].
    Park MK; Lee JH; Byun YH; Lee HIe; Gwak GY; Choi MS; Koh KC; Paik SW; Yoo BC; Rhee JC
    Korean J Hepatol; 2007 Sep; 13(3):370-7. PubMed ID: 17898553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial epidemiology and antimicrobial resistance in ascitic fluid: a 2-year retrospective study.
    Piroth L; Pechinot A; Minello A; Jaulhac B; Patry I; Hadou T; Hansmann Y; Rabaud C; Chavanet P; Neuwirth C
    Scand J Infect Dis; 2009; 41(11-12):847-51. PubMed ID: 19922067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spontaneous bacterial peritonitis in patients with cirrhosis].
    Nousbaum JB
    Presse Med; 2015 Dec; 44(12 Pt 1):1235-42. PubMed ID: 26358667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.
    Dever JB; Sheikh MY
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1116-31. PubMed ID: 25819304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging pharmacotherapy for the treatment of bacterial peritonitis.
    Maraolo AE; Gentile I; Pinchera B; Nappa S; Borgia G
    Expert Opin Pharmacother; 2018 Aug; 19(12):1317-1325. PubMed ID: 30071176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.